Table 3.
Correlations Between Real World Functioning Variables and Predictor Variables
| Mt. Sinai Sample | VALERO I | VALERO II | SCOPE | |||||
|---|---|---|---|---|---|---|---|---|
| n=233 | n=195 | n=214 | n=179 | |||||
| Everyday Functioning Variable | ||||||||
| r | p | r | p | r | p | r | p | |
| SLOF Interpersonal Functions | ||||||||
| Negative Symptoms | −.42 | .001 | −.41 | .001 | −.39 | .001 | −.38 | .001 |
| UPSA-B | −.10 | .15 | .13 | .07 | .16 | .06 | .19 | .05 |
| Cognition Composite | .10 | .15 | .13 | .07 | .16 | .06 | .15 | .06 |
| BDI total Scores | − .14 | .08 | − .34 | .001 | .00 | .99 | −.18 | .05 |
| SLOF Activities Subscale | ||||||||
| Negative Symptoms | −.10 | .15 | −.11 | .16 | −.08 | .27 | −.09 | .20 |
| UPSA-B | .42 | .001 | .36 | .001 | .39 | .001 | .29 | .001 |
| Cognition Composite | .30 | .001 | .32 | .001 | .29 | .001 | .26 | .001 |
| BDI total Scores | .06 | .46 | .25 | .002 | .04 | .83 | −.07 | .36 |
| SLOF Vocational Subscale | ||||||||
| Negative Symptoms | −.08 | .27 | −.12 | .11 | −.10 | .15 | −.11 | .16 |
| UPSA-B | .30 | .001 | .32 | .001 | .28 | .001 | .21 | .003 |
| Cognition Composite | .20 | .005 | .26 | .002 | .23 | .005 | .28 | .001 |
| BDI total Scores | .10 | .15 | .23 | .004 | .07 | .48 | −.04 | .57 |
Note. Mt. Sinai Patients are from New York; Valero I patients are from Atlanta and San Diego; Valero II patients are from Atlanta, San Diego, and Miami; SCOPE patients are from Miami and Dallas.